9th percentile
Founder and CEO building AI-powered rare disease biotech at Maddie BioGenetics
Credibility
Operator · 15th percentile
- Current founder and CEO of Maddie BioGenetics, an AI-powered biotech startup focused on personalized medicine for rare diseases.
Relationship Matrix
Most Like You
Most Complimentary
Founder score
- 82%Probability of being accurate (82%)Current founder and CEO of Maddie BioGenetics, an AI-powered biotech startup focused on personalized medicine for rare diseases.
What you likely need
You're an early-stage founder at Maddie BioGenetics with a strong domain background in AI, cybersecurity, and enterprise tech, but your startup has minimal public footprint and no verified funding yet. Your next priority is establishing credibility through press coverage, partnerships, and a seed raise to validate the biotech thesis. Building a public signal around your AI + rare disease angle will be critical for attracting both capital and clinical partners.
Would you attend these IRL Festival events?
We will tune and customize your Founder Festival experience to make sure you get invited to the events that would be most valuable to you.
- fundraisingPursue a pre-seed or seed round from biotech-focused angels and micro-VCs — your AI + rare disease angle is fundable but needs a public pitch deck and press coverage to attract inbound interest.
- positioningPublish your founder story (a father building AI-driven solutions for autism) on platforms like TechCrunch, STAT News, or MedCity News to build credibility and inbound deal flow.
- introsLeverage your SoftBank and Hitachi network to get warm introductions to corporate venture arms (SoftBank Vision Fund Health, Hitachi Ventures) that back AI-in-healthcare startups.
- tacticalApply for NIH SBIR/STTR grants focused on rare disease and autism research — non-dilutive funding is especially valuable at your stage and adds scientific credibility.
- hiringRecruit a scientific advisory board with published researchers in autism genetics or drug repurposing to strengthen your clinical credibility with investors and partners.
- positioningOpen-source a lightweight AI tool or dataset related to your rare disease work on GitHub to build developer and researcher community signal around Maddie BioGenetics.
- wellbeingWith a 6-person team across multiple geographies (US, Qatar, China) and a deeply personal mission, establish clear operational rhythms early to avoid founder burnout.